GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Gains from Investment Securities (2009 - 2024)

Updated

Analysis

GT Biopharma (GTBP) Gains from Investment Securities (2009 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 GT Biopharma 6.65 Mn -16.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -2,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 -2,000.00
Dec 31, 2023 5,000.00
Sep 30, 2023 81,000.00
Jun 30, 2023 -67,000.00
Mar 31, 2023 29,000.00
Dec 31, 2022 38,000.00
Sep 30, 2022 58,000.00
Jun 30, 2022 -6,000.00
Mar 31, 2022 -24,000.00
Dec 31, 2021 168,000.00
Sep 30, 2021 502,000.00
Jun 30, 2021 -480,000.00
Mar 31, 2021 21,000.00
Sep 30, 2017 1.45 Mn
Jun 30, 2017 367,000.00
Mar 31, 2017 -2.74 Mn
Dec 31, 2016 11.50 Mn
Sep 30, 2016 -11.70 Mn
API Access

GT Biopharma Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=GTBP&period=max&api_key=YOUR_API_KEY